{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:41:51Z","timestamp":1791499311826,"version":"4.3.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172866"],"award-info":[{"award-number":["82172866"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2021LZL005"],"award-info":[{"award-number":["ZR2021LZL005"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2019LZL019"],"award-info":[{"award-number":["ZR2019LZL019"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Science & Technology of Shandong Province","award":["2021CXGC011102"],"award-info":[{"award-number":["2021CXGC011102"]}]},{"name":"Start-up fund of Shandong Cancer Hospital","award":["2020PYA04"],"award-info":[{"award-number":["2020PYA04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Anti-PD-(L)1 immunotherapy has been recommended for non-small cell lung cancer (NSCLC) patients with lymph node metastases (LNM). However, the exact functional feature and spatial architecture of tumor-infiltrating CD8\u2009+\u2009T cells remain unclear in these patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Tissue microarrays (TMAs) from 279 IA-IIIB NSCLC samples were stained by multiplex immunofluorescence (mIF) for 11 markers (CD8, CD103, PD-1, Tim3, GZMB, CD4, Foxp3, CD31, \u03b1SMA, Hif-1\u03b1, pan-CK). We evaluated the density of CD8\u2009+\u2009T-cell functional subsets, the mean nearest neighbor distance (mNND) between CD8\u2009+\u2009T cells and neighboring cells, and the cancer-cell proximity score (CCPS) in invasive margin (IM) as well as tumor center (TC) to investigate their relationships with LNM and prognosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The densities of CD8\u2009+\u2009T-cell functional subsets, including predysfunctional CD8\u2009+\u2009T cells (T<jats:sub>predys<\/jats:sub>) and dysfunctional CD8\u2009+\u2009T cells (T<jats:sub>dys<\/jats:sub>), in IM predominated over those in TC (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Multivariate analysis identified that the densities of CD8\u2009+\u2009T<jats:sub>predys<\/jats:sub> cells in TC and CD8\u2009+\u2009T<jats:sub>dys<\/jats:sub> cells in IM were significantly associated with LNM [OR\u2009=\u20090.51, 95%CI (0.29\u20130.88), <jats:italic>P<\/jats:italic>\u2009=\u20090.015; OR\u2009=\u20095.80, 95%CI (3.19\u201310.54), <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001; respectively] and recurrence-free survival (RFS) [HR\u2009=\u20090.55, 95%CI (0.34\u20130.89), <jats:italic>P<\/jats:italic>\u2009=\u20090.014; HR\u2009=\u20092.49, 95%CI (1.60\u20134.13), <jats:italic>P<\/jats:italic>\u2009=\u20090.012; respectively], independent of clinicopathological factors. Additionally, shorter mNND between CD8\u2009+\u2009T cells and their neighboring immunoregulatory cells indicated a stronger interplay network in the microenvironment of NSCLC patients with LNM and was associated with worse prognosis. Furthermore, analysis of CCPS suggested that cancer microvessels (CMVs) and cancer-associated fibroblasts (CAFs) selectively hindered CD8\u2009+\u2009T cells from contacting with cancer cells, and were associated with the dysfunction of CD8\u2009+\u2009T cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Tumor-infiltrating CD8\u2009+\u2009T cells were in a more dysfunctional status and in a more immunosuppressive microenvironment in patients with LNM compared with those without LNM.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-023-04154-y","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T13:04:14Z","timestamp":1683896654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Functional status and spatial architecture of tumor-infiltrating CD8+\u2009T cells are associated with lymph node metastases in non-small cell lung cancer"],"prefix":"10.1186","volume":"21","author":[{"given":"Guanqun","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaozhuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jujie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligang","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8520-9556","authenticated-orcid":false,"given":"Xiaorong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,12]]},"reference":[{"issue":"12","key":"4154_CR1","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1097\/JTO.0000000000000678","volume":"10","author":"H Asamura","year":"2015","unstructured":"Asamura H, Chansky K, Crowley J, Goldstraw P, Rusch VW, Vansteenkiste JF, et al. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming 8thedition of the TNM classification for lung cancer. J Thorac Oncol. 2015;10(12):1675\u201384.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"4154_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1001\/jamaoncol.2017.2993","volume":"4","author":"MP Smeltzer","year":"2018","unstructured":"Smeltzer MP, Faris NR, Ray MA, Osarogiagbon RU. Association of pathologic nodal staging quality with survival among patients with non-small cell lung cancer after resection with curative intent. JAMA Oncol. 2018;4(1):80\u20137.","journal-title":"JAMA Oncol"},{"issue":"6","key":"4154_CR3","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1200\/JCO.21.01589","volume":"40","author":"JE Chaft","year":"2022","unstructured":"Chaft JE, Shyr Y, Sepesi B, Forde PM. Preoperative and postoperative systemic therapy for operable non-small-cell lung cancer. J Clin Oncol. 2022;40(6):546\u201355.","journal-title":"J Clin Oncol"},{"issue":"4","key":"4154_CR4","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/0284186X.2021.2012253","volume":"61","author":"W Haque","year":"2022","unstructured":"Haque W, Singh A, Park HS, Teh BS, Butler EB, Zeng M, et al. Quantifying the rate and predictors of occult lymph node involvement in patients with clinically node-negative non-small cell lung cancer. Acta Oncol. 2022;61(4):403\u20138.","journal-title":"Acta Oncol"},{"key":"4154_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fimmu.2018.00014","volume":"9","author":"A Durgeau","year":"2018","unstructured":"Durgeau A, Virk Y, Corgnac S, Mami-Chouaib F. Recent advances in targeting CD8+ T-Cell immunity for more effective cancer immunotherapy. Front Immunol. 2018;9:14.","journal-title":"Front Immunol"},{"issue":"3","key":"4154_CR6","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1093\/ejcts\/ezaa098","volume":"58","author":"G Bocchialini","year":"2020","unstructured":"Bocchialini G, Lagrasta C, Madeddu D, Mazzaschi G, Marturano D, Sogni F, et al. Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancer. Eur J Cardiothorac Surg. 2020;58(3):619\u201328.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"11","key":"4154_CR7","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1158\/1078-0432.CCR-14-1905","volume":"21","author":"T Donnem","year":"2015","unstructured":"Donnem T, Hald SM, Paulsen EE, Richardsen E, Al-Saad S, Kilvaer TK, et al. Stromal CD8+ T-cell density\u2014a promising supplement to TNM staging in non-small cell lung cancer. Clin Cancer Res. 2015;21(11):2635\u201343.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"4154_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0242173","volume":"15","author":"B Chen","year":"2020","unstructured":"Chen B, Li H, Liu C, Xiang X, Wang S, Wu A, et al. Prognostic value of the common tumour-infiltrating lymphocyte subtypes for patients with non-small cell lung cancer: a meta-analysis. PLoS ONE. 2020;15(11): e0242173.","journal-title":"PLoS ONE"},{"issue":"6","key":"4154_CR9","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1183\/13993003.00176-2014","volume":"46","author":"DS O'Callaghan","year":"2015","unstructured":"O\u2019Callaghan DS, Rexhepaj E, Gately K, Coate L, Delaney D, O\u2019Donnell DM, et al. Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer. Eur Respir J. 2015;46(6):1762\u201372.","journal-title":"Eur Respir J"},{"issue":"1","key":"4154_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40425-018-0488-6","volume":"7","author":"KSS Enfield","year":"2019","unstructured":"Enfield KSS, Martin SD, Marshall EA, Kung SHY, Gallagher P, Milne K, et al. Hyperspectral cell sociology reveals spatial tumor-immune cell interactions associated with lung cancer recurrence. J Immunother Cancer. 2019;7(1):13.","journal-title":"J Immunother Cancer"},{"key":"4154_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.lungcan.2018.01.022","volume":"117","author":"S Barua","year":"2018","unstructured":"Barua S, Fang P, Sharma A, Fujimoto J, Wistuba I, Rao AUK, et al. Spatial interaction of tumor cells and regulatory T cells correlates with survival in non-small cell lung cancer. Lung Cancer. 2018;117:73\u20139.","journal-title":"Lung Cancer"},{"issue":"1","key":"4154_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1155","volume":"13","author":"H Peng","year":"2023","unstructured":"Peng H, Wu X, Liu S, He M, Xie C, Zhong R, et al. Multiplex immunofluorescence and single-cell transcriptomic profiling reveal the spatial cell interaction networks in the non-small cell lung cancer microenvironment. Clin Transl Med. 2023;13(1): e1155.","journal-title":"Clin Transl Med"},{"issue":"4","key":"4154_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41568-019-0235-4","volume":"20","author":"AM van der Leun","year":"2020","unstructured":"van der Leun AM, Thommen DS, Schumacher TN. CD8(+) T cell states in human cancer: insights from single-cell analysis. Nat Rev Cancer. 2020;20(4):218\u201332.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"4154_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002780","volume":"9","author":"CG Kim","year":"2021","unstructured":"Kim CG, Kim G, Kim KH, Park S, Shin S, Yeo D, et al. Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer. J Immunother Cancer. 2021;9(12): e002780.","journal-title":"J Immunother Cancer"},{"issue":"11","key":"4154_CR15","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/intimm\/dxac038","volume":"34","author":"S Ando","year":"2022","unstructured":"Ando S, Araki K. CD8 T-cell heterogeneity during T-cell exhaustion and PD-1-targeted immunotherapy. Int Immunol. 2022;34(11):571\u20137.","journal-title":"Int Immunol"},{"issue":"12","key":"4154_CR16","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1158\/2326-6066.CIR-15-0097","volume":"3","author":"DS Thommen","year":"2015","unstructured":"Thommen DS, Schreiner J, M\u00fcller P, Herzig P, Roller A, Belousov A, et al. Progression of lung cancer is associated with increased dysfunction of T cells defined by coexpression of multiple inhibitory receptors. Cancer Immunol Res. 2015;3(12):1344\u201355.","journal-title":"Cancer Immunol Res"},{"issue":"2","key":"4154_CR17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1158\/1078-0432.CCR-17-2156","volume":"24","author":"G Mazzaschi","year":"2018","unstructured":"Mazzaschi G, Madeddu D, Falco A, Bocchialini G, Goldoni M, Sogni F, et al. Low PD-1 expression in cytotoxic CD8(+) tumor-infiltrating lymphocytes confers an immune-privileged tissue microenvironment in NSCLC with a prognostic and predictive value. Clin Cancer Res. 2018;24(2):407\u201319.","journal-title":"Clin Cancer Res"},{"key":"4154_CR18","doi-asserted-by":"publisher","first-page":"634059","DOI":"10.3389\/fonc.2021.634059","volume":"11","author":"D Su","year":"2021","unstructured":"Su D, Wu G, Xiong R, Sun X, Xu M, Mei Y, et al. Tumor immune microenvironment characteristics and their prognostic value in non-small-cell lung cancer. Front Oncol. 2021;11:634059.","journal-title":"Front Oncol"},{"issue":"7","key":"4154_CR19","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41591-018-0045-3","volume":"24","author":"X Guo","year":"2018","unstructured":"Guo X, Zhang Y, Zheng L, Zheng C, Song J, Zhang Q, et al. Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing. Nat Med. 2018;24(7):978\u201385.","journal-title":"Nat Med"},{"key":"4154_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3389\/fonc.2013.00231","volume":"3","author":"M Bellone","year":"2013","unstructured":"Bellone M, Calcinotto A. Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytes. Front Oncol. 2013;3:231.","journal-title":"Front Oncol"},{"issue":"6","key":"4154_CR21","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nm.3541","volume":"20","author":"GT Motz","year":"2014","unstructured":"Motz GT, Santoro SP, Wang LP, Garrabrant T, Lastra RR, Hagemann IS, et al. Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors. Nat Med. 2014;20(6):607\u201315.","journal-title":"Nat Med"},{"issue":"11","key":"4154_CR22","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1158\/2159-8290.CD-21-1714","volume":"12","author":"JA Grout","year":"2022","unstructured":"Grout JA, Sirven P, Leader AM, Maskey S, Hector E, Puisieux I, et al. Spatial positioning and matrix programs of cancer-associated fibroblasts promote T cell exclusion in human lung tumors. Cancer Discov. 2022;12(11):2606\u201325.","journal-title":"Cancer Discov"},{"issue":"4","key":"4154_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/cac2.12023","volume":"40","author":"WCC Tan","year":"2020","unstructured":"Tan WCC, Nerurkar SN, Cai HY, Ng HHM, Wu D, Wee YTF, et al. Overview of multiplex immunohistochemistry\/immunofluorescence techniques in the era of cancer immunotherapy. Cancer Commun. 2020;40(4):135\u201353.","journal-title":"Cancer Commun"},{"issue":"1","key":"4154_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000155","volume":"8","author":"JM Taube","year":"2020","unstructured":"Taube JM, Akturk G, Angelo M, Engle EL, Gnjatic S, Greenbaum S, et al. The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation. J Immunother Cancer. 2020;8(1): e000155.","journal-title":"J Immunother Cancer"},{"issue":"2","key":"4154_CR25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/annonc\/mdv560","volume":"27","author":"T Donnem","year":"2016","unstructured":"Donnem T, Kilvaer TK, Andersen S, Richardsen E, Paulsen EE, Hald SM, et al. Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer. Ann Oncol. 2016;27(2):225\u201332.","journal-title":"Ann Oncol"},{"issue":"327","key":"4154_CR26","doi-asserted-by":"publisher","first-page":"32726","DOI":"10.1126\/scitranslmed.aad6352","volume":"8","author":"B Mlecnik","year":"2016","unstructured":"Mlecnik B, Bindea G, Kirilovsky A, Angell HK, Obenauf AC, Tosolini M, et al. The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis. Sci Transl Med. 2016;8(327):32726.","journal-title":"Sci Transl Med"},{"issue":"20","key":"4154_CR27","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1158\/0008-5472.CAN-20-0069","volume":"80","author":"Z Xiang","year":"2020","unstructured":"Xiang Z, Andreas W, Simone R, Stefan G, Siavash M, Birgit B, et al. Spatial Density and distribution of tumor-associated macrophages predict survival in non-small-cell lung carcinoma. Can Res. 2020;80(20):4414\u201325.","journal-title":"Can Res"},{"issue":"4","key":"4154_CR28","first-page":"215","volume":"19","author":"H Salmon","year":"2019","unstructured":"Salmon H, Remark R, Gnjatic S, Merad M. Host tissue determinants of tumour immunity. Nat Rev Cancer. 2019;19(4):215\u201327.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"4154_CR29","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","volume":"20","author":"D Bruni","year":"2020","unstructured":"Bruni D, Angell HK, Galon J. The immune contexture and immunoscore in cancer prognosis and therapeutic efficacy. Nat Rev Cancer. 2020;20(11):662\u201380.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"4154_CR30","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/jamaoncol.2022.6898","volume":"9","author":"B Zhang","year":"2023","unstructured":"Zhang B, Zhong H, Han B. Neoadjuvant immunotherapy for patients with non-small cell lung cancer-is a new era coming? JAMA Oncol. 2023;9(3):301\u20132.","journal-title":"JAMA Oncol"},{"issue":"3","key":"4154_CR31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","volume":"18","author":"J Galon","year":"2019","unstructured":"Galon J, Bruni D. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nat Rev Drug Discovery. 2019;18(3):197\u2013218.","journal-title":"Nat Rev Drug Discovery"},{"issue":"3","key":"4154_CR32","first-page":"435","volume":"107","author":"SK Abu","year":"2015","unstructured":"Abu SK, Jason B, Daniel C-H, Joseph M, Vamsidhar V, et al. Objective measurement and clinical significance of TILs in non-small cell lung cancer. J Nat Cancer Institute. 2015;107(3):435.","journal-title":"J Nat Cancer Institute."},{"issue":"5","key":"4154_CR33","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.21037\/jtd-19-3414a","volume":"12","author":"AB Schulze","year":"2020","unstructured":"Schulze AB, Evers G, G\u00f6rlich D, Mohr M, Marra A, Hillejan L, et al. Tumor infiltrating T cells influence prognosis in stage I-III non-small cell lung cancer. J Thorac Dis. 2020;12(5):1824\u201342.","journal-title":"J Thorac Dis"},{"key":"4154_CR34","doi-asserted-by":"publisher","first-page":"175883592098497","DOI":"10.1177\/1758835920984975","volume":"13","author":"W Feng","year":"2021","unstructured":"Feng W, Li Y, Shen L, Zhang Q, Cai XW, Zhu ZF, et al. Clinical impact of the tumor immune microenvironment in completely resected stage IIIA(N2) non-small cell lung cancer based on an immunoscore approach. Ther Adv Med Oncol. 2021;13:1758835920984975.","journal-title":"Ther Adv Med Oncol"},{"issue":"2","key":"4154_CR35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.lungcan.2003.11.004","volume":"44","author":"A Trojan","year":"2004","unstructured":"Trojan A, Urosevic M, Dummer R, Giger R, Weder W, Stahel RA. Immune activation status of CD8+ T cells infiltrating non-small cell lung cancer. Lung Cancer. 2004;44(2):143\u20137.","journal-title":"Lung Cancer"},{"issue":"1","key":"4154_CR36","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s43018-021-00292-8","volume":"3","author":"B Liu","year":"2022","unstructured":"Liu B, Hu X, Feng K, Gao R, Xue Z, Zhang S, et al. Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer. Nature Cancer. 2022;3(1):108\u201321.","journal-title":"Nature Cancer"},{"key":"4154_CR37","doi-asserted-by":"publisher","first-page":"10501","DOI":"10.1038\/ncomms10501","volume":"7","author":"S Koyama","year":"2016","unstructured":"Koyama S, Akbay EA, Li YY, Herter-Sprie GS, Buczkowski KA, Richards WG, et al. Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints. Nat Commun. 2016;7:10501.","journal-title":"Nat Commun"},{"issue":"4","key":"4154_CR38","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2018.11.043","volume":"176","author":"H Li","year":"2019","unstructured":"Li H, van der Leun AM, Yofe I, Lubling Y, Gelbard-Solodkin D, van Akkooi ACJ, et al. Dysfunctional CD8+ T cells form a proliferative, dynamically regulated compartment within human melanoma. Cell. 2019;176(4):775\u201389.","journal-title":"Cell"},{"key":"4154_CR39","doi-asserted-by":"publisher","first-page":"764596","DOI":"10.3389\/fimmu.2021.764596","volume":"12","author":"A Frafjord","year":"2021","unstructured":"Frafjord A, Buer L, Hammarstr\u00f6m C, Aamodt H, Woldb\u00e6k PR, Brustugun OT, et al. The immune landscape of human primary lung tumors is Th2 skewed. Front Immunol. 2021;12:764596.","journal-title":"Front Immunol"},{"issue":"10","key":"4154_CR40","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1084\/jem.185.10.1837","volume":"185","author":"X Zhang","year":"1997","unstructured":"Zhang X, Brunner T, Carter L, Dutton RW, Rogers P, Bradley L, et al. Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas\/FasL-mediated apoptosis. J Exp Med. 1997;185(10):1837\u201349.","journal-title":"J Exp Med"},{"issue":"6","key":"4154_CR41","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1189\/jlb.0509352","volume":"87","author":"Y Fang","year":"2010","unstructured":"Fang Y, Yu S, Ellis JS, Sharav T, Braley-Mullen H. Comparison of sensitivity of Th1, Th2, and Th17 cells to Fas-mediated apoptosis. J Leukoc Biol. 2010;87(6):1019\u201328.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"4154_CR42","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/s41467-018-03347-0","volume":"9","author":"MA Lakins","year":"2018","unstructured":"Lakins MA, Ghorani E, Munir H, Martins CP, Shields JD. Cancer-associated fibroblasts induce antigen-specific deletion of CD8 (+) T Cells to protect tumour cells. Nat Commun. 2018;9(1):948.","journal-title":"Nat Commun"},{"issue":"6","key":"4154_CR43","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nrclinonc.2016.211","volume":"14","author":"RR Weichselbaum","year":"2017","unstructured":"Weichselbaum RR, Liang H, Deng L, Fu YX. Radiotherapy and immunotherapy: a beneficial liaison? Nat Rev Clin Oncol. 2017;14(6):365\u201379.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"4154_CR44","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41419-017-0061-0","volume":"9","author":"MB Schaaf","year":"2018","unstructured":"Schaaf MB, Garg AD, Agostinis P. Defining the role of the tumor vasculature in antitumor immunity and immunotherapy. Cell Death Dis. 2018;9(2):115.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4154_CR45","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13045-017-0456-5","volume":"10","author":"A Somasundaram","year":"2017","unstructured":"Somasundaram A, Burns TF. The next generation of immunotherapy: keeping lung cancer in check. J Hematol Oncol. 2017;10(1):87.","journal-title":"J Hematol Oncol"},{"issue":"21","key":"4154_CR46","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1056\/NEJMoa1716078","volume":"378","author":"PM Forde","year":"2018","unstructured":"Forde PM, Chaft JE, Smith KN, Anagnostou V, Cottrell TR, Hellmann MD, et al. Neoadjuvant PD-1 blockade in resectable lung cancer. N Engl J Med. 2018;378(21):1976\u201386.","journal-title":"N Engl J Med"},{"issue":"5","key":"4154_CR47","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1182\/blood-2005-06-2345","volume":"107","author":"T Baba","year":"2006","unstructured":"Baba T, Ishizu A, Iwasaki S, Suzuki A, Tomaru U, Ikeda H, et al. CD4+\/CD8+ macrophages infiltrating at inflammatory sites: a population of monocytes\/macrophages with a cytotoxic phenotype. Blood. 2006;107(5):2004\u201312.","journal-title":"Blood"},{"key":"4154_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.ircmb.2019.07.004","volume":"348","author":"S Balan","year":"2019","unstructured":"Balan S, Saxena M, Bhardwaj N. Dendritic cell subsets and locations. Int Rev Cell Mol Biol. 2019;348:1\u201368.","journal-title":"Int Rev Cell Mol Biol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04154-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04154-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04154-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T14:04:43Z","timestamp":1683900283000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04154-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,12]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4154"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04154-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,12]]},"assertion":[{"value":"24 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Review Committee of Shandong Cancer Hospital (SDTHEC2022007013) and complied with the provisions of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"320"}}